Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
A Systematic Review of Long Non-Coding Rnas With a Potential Role in Breast Cancer Publisher Pubmed



Heidari R1, 2 ; Akbariqomi M2 ; Asgari Y1 ; Ebrahimi D3 ; Alinejadrokny H4, 5, 6
Authors

Source: Mutation Research - Reviews in Mutation Research Published:2021


Abstract

The human transcriptome contains many non-coding RNAs (ncRNAs), which play important roles in gene regulation. Long noncoding RNAs (lncRNAs) are an important class of ncRNAs with lengths between 200 and 200,000 bases. Unlike mRNA, lncRNA lacks protein-coding features, specifically, open-reading frames, and start and stop codons. LncRNAs have been reported to play a role in the pathogenesis and progression of many cancers, including breast cancer (BC), acting as tumor suppressors or oncogenes. In this review, we systematically mined the literature to identify 65 BC-related lncRNAs. We then perform an integrative bioinformatics analysis to identify 14 lncRNAs with a potential regulatory role in BC. The biological function of these 14 lncRNAs, their regulatory mechanisms, and roles in the initiation and progression of BC are discussed in this review. Additionally, we elaborate on the current and future applications of lncRNAs as diagnostic and/or therapeutic biomarkers in BC. © 2021 Elsevier B.V.
Other Related Docs
4. Critical Roles of Long Noncoding Rnas in Breast Cancer, Journal of Cellular Physiology (2020)
7. Modulation of Cancer Cell Signaling by Long Noncoding Rnas, Journal of Cellular Biochemistry (2019)
8. Metformin and Long Non-Coding Rnas in Breast Cancer, Journal of Translational Medicine (2023)
11. Potential Roles of Lncrna-Xist/Mirnas/Mrnas in Human Cancer Cells, Clinical and Translational Oncology (2023)
13. Role of Non-Coding Rnas in Neuroblastoma, Cancer Gene Therapy (2023)
16. Long Non-Coding Rnas As Epigenetic Regulators in Cancer, Current Pharmaceutical Design (2019)
18. Lncrnas Roles in Chemoresistance of Cancer Cells, Current Molecular Medicine (2022)